|
1
|
Pang Y, Kartsonaki C, Turnbull I, Guo Y,
Clarke R, Chen Y, Bragg F, Yang L, Bian Z, Millwood IY, et al:
Diabetes, plasma glucose and incidence of fatty liver, cirrhosis
and liver cancer: A prospective study of 0.5 million people.
Hepatology. 68:1308–1318. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the Global
Burden of Disease Study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Costentin CE, Layese R, Bourcier V, Cagnot
C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan
D, et al: Compliance with hepatocellular carcinoma surveillance
guidelines associated with increased lead-time adjusted survival of
patients with compensated viral cirrhosis. Gastroenterology.
155:431–442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boot A, Huang MN, Ng AWT, Ho SC, Lim JQ,
Kawakami Y, Chayama K, Teh BT, Nakagawa H and Rozen SG: In-depth
characterization of the cisplatin mutational signature in human
cell lines and in esophageal and liver tumors. Genome Res.
28:654–665. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hama N, Totoki Y, Miura F, Tatsuno K,
Saito-Adachi M, Nakamura H, Arai Y, Hosoda F, Urushidate T, Ohashi
S, et al: Epigenetic landscape influences the liver cancer genome
architecture. Nat Commun. 9:16432018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Collino A, Termanini A, Nicoli P, Diaferia
G, Polletti S, Recordati C, Castiglioni V, Caruso D, Mitro N,
Natoli G and Ghisletti S: Sustained activation of detoxification
pathways promotes liver carcinogenesis in response to chronic bile
acid-mediated damage. PLoS Genet. 14:e10073802018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li G, Liang Y, Sun C, Peng X, Hao N, Liu
M, Gao W, Wu H and He B: Effective combination therapy of
percutaneous ethanol injection and chemotherapy based on injectable
low molecular weight gels. Artif Cells Nanomed Biotechnol. 9:1–11.
2018. View Article : Google Scholar
|
|
8
|
Chaturvedi M, Schilling J, Beautrait A,
Bouvier M, Benovic JL and Shukla AK: Emerging paradigm of
intracellular targeting of G protein-coupled receptors. Trends
Biochem Sci. 43:533–546. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Renard D: Cerebral microbleeds: A magnetic
resonance imaging review of common and less common causes. Eur J
Neurol. 25:441–450. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan M, Yamaguchi S, Nakamura M and
Nagamune T: Real-time monitoring of pH-dependent intracellular
trafficking of ovarian cancer G protein-coupled receptor 1 in
living leukocytes. J Biosci Bioeng. 126:363–370. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bedini A, Baiula M, Vincelli G, Formaggio
F, Lombardi S, Caprini M and Spampinato S: Nociceptin/orphanin FQ
antagonizes lipopolysaccharide-stimulated proliferation, migration
and inflammatory signaling in human glioblastoma U87 cells. Biochem
Pharmacol. 140:89–104. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song X, Zhu S, Xie Y, Liu J, Sun L, Zeng
D, Wang P, Ma X, Kroemer G, Bartlett DL, et al: JTC801 Induces
pH-dependent death specifically in cancer cells and slows growth of
tumors in mice. Gastroenterology. 154:1480–1493. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng CJ, Yang LL, Liu J and Zhong L:
JTC-801 exerts anti-proliferative effects in human osteosarcoma
cells by inducing apoptosis. J Recept Signal Transduct Res.
38:133–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Y, Simpson-Durand CD and Standifer
KM: Nociceptin/orphanin FQ peptide receptor antagonist JTC-801
reverses pain and anxiety symptoms in a rat model of post-traumatic
stress disorder. Br J Pharmacol. 172:571–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Witkin JM, Statnick MA, Rorick-Kehn LM,
Pintar JE, Ansonoff M, Chen Y, Tucker RC and Ciccocioppo R: The
biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity,
stress, anxiety, mood, and drug dependence. Pharmacol Ther.
141:283–299. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li JX, Bi YP, Wang J, Yang X, Tian YF and
Sun ZF: JTC-801 inhibits the proliferation and metastasis of
ovarian cancer cell SKOV3 through inhibition of the PI3K-AKT
signaling pathway. Die Pharmazie. 73:283–287. 2018.PubMed/NCBI
|
|
17
|
da Silva JA, Biagioni AF, Almada RO, de
Freitas RL and Coimbra NC: Panicolytic-like effects caused by
substantia nigra pars reticulata pretreatment with low doses of
endomorphin-1 and high doses of CTOP or the NOP receptors
antagonist JTC-801 in male Rattus norvegicus. Psychopharmacology
(Berl). 234:3009–3025. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rybczynska AA, Boersma HH, de Jong S,
Gietema JA, Noordzij W, Dierckx RAJO, Elsinga PH and van Waarde A:
Avenues to molecular imaging of dying cells: Focus on cancer. Med
Res Rev. 38:1713–1768. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ucker DS and Levine JS: Exploitation of
apoptotic regulation in cancer. Front Immunol. 9:2412018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang C, Ma S, Hu R, Wang X, Li M, Tian F,
Jiang W, Zhu L and Bian Z: Effect of CXCR4 on apoptosis in
osteosarcoma cells via the PI3K/Akt/NF-κβ signaling pathway. Cell
Physiol Biochem. 46:2250–2260. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carroll MJ, Fogg KC, Patel HA, Krause HB,
Mancha AS, Patankar MS, Weisman PS, Barroilhet L and Kreeger PK:
Alternatively activated macrophages upregulate mesothelial
expression of P-selectin to enhance adhesion of ovarian cancer
cells. Cancer Res. 78:3560–3573. 2018.PubMed/NCBI
|
|
22
|
De Santis MC, Porporato PE, Martini M and
Morandi A: Signaling pathways regulating redox balance in cancer
metabolism. Front Oncol. 8:1262018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jondal DA, Thompson SM, Butters KA,
Knudsen BE, Anderson JL, Carter RE, Roberts LR, Callstrom MR and
Woodrum DA: Heat stress and hepatic laser thermal ablation induce
hepatocellular carcinoma growth: Role of PI3K/mTOR/AKT signaling.
Radiology. 288:730–738. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim EJ, Kang GJ, Kang JI, Boo HJ, Hyun JW,
Koh YS, Chang WY, Kim YR, Kwon JM, Maeng YH, et al: Over-activation
of AKT signaling leading to 5-Fluorouracil resistance in
SNU-C5/5-FU cells. Oncotarget. 9:19911–19928. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo Y, Wang F, Li H, Liang H, Li Y, Gao Z
and He X: Metformin protects against spinal cord injury by
regulating autophagy via the mTOR signaling pathway. Neurochem Res.
2018.[Epub ahead of print]. View Article : Google Scholar
|
|
26
|
Yamazaki S, Higuchi Y, Ishibashi M,
Hashimoto H, Yasunaga M, Matsumura Y, Tsuchihara K, Tsuboi M, Goto
K, Ochiai A and Ishii G: Collagen type I induces EGFR-TKI
resistance in EGFR-mutated cancer cells via mTOR activation through
Akt-independent pathway. Cancer Sci. 109:2063–2073. 2018.
View Article : Google Scholar : PubMed/NCBI
|
